Related by context. All words. (Click for frequent words.) 66 reintervention 64 binary restenosis 64 diameter stenosis 64 endoleak 63 reoperation 63 wedge resection 62 recanalization 62 pneumonectomy 62 infarct size 61 PSA nadir 61 stent binary restenosis 61 graft patency 61 lumbar disc herniation 60 left ventricular LV 60 luminal diameter 60 aneurysmal 60 ascending aortic 60 segmentectomy 60 anastomotic leak 60 dyssynchrony 60 primary patency 60 RVOT 60 balloon valvuloplasty 60 mediastinal 60 cystectomy 60 percutaneous intervention 60 lateral radiograph 60 biochemical recurrence 60 prespecified 60 rebleeding 60 pT3 60 radial artery grafts 59 tortuosity 59 intra arterial 59 angiographic restenosis 59 biopsy Gleason 59 sternotomy 59 postoperative complication 59 saphenous vein graft 59 hepatectomy 59 extracapsular extension 59 tricuspid regurgitation 59 pericardial effusion 59 tumor resection 59 intraoperative complications 59 stent implantation 59 atheroma volume 59 neointimal 59 morphometric vertebral fractures 59 posterolateral fusion 59 coronary stenosis 58 creatine kinase MB 58 lumen diameter 58 parenchymal 58 computed tomographic scan 58 P = .# 58 plication 58 biochemical relapse 58 transurethral resection 58 Operative mortality 58 intima media thickness 58 carotid endarterectomy CEA 58 femoral neck fracture 58 leukocyte count 58 ejection fractions 58 Target Lesion Revascularization TLR 58 locoregional recurrence 58 seminal vesicle invasion 58 QRS duration 58 intrahepatic 58 lymphadenectomy 58 patency 58 splenic artery 58 lobectomy 58 OPCAB 58 carotid artery stenosis 58 left ventricular systolic 58 urodynamic parameters 58 revascularisation 58 peritumoral 58 pseudoaneurysm 58 opacification 58 nonoperative treatment 58 CR nPR 57 ureteral 57 vein grafts 57 perioperative mortality 57 bypass grafting 57 thrombosed 57 radical prostatectomy RP 57 distal anastomosis 57 liver resection 57 NYHA functional class 57 hilar 57 stenotic 57 colorectal metastases 57 death reinfarction 57 segment binary restenosis 57 antegrade 57 sonographically 57 stent grafting 57 undetectable HBV DNA 57 occlusions 57 femoral shaft fracture 57 pretest probability 57 septal 57 urgent revascularization 57 revascularized 57 tamponade 57 underwent resection 57 periprocedural 57 secondary efficacy endpoint 57 intravascular ultrasonography 57 transthoracic 57 intravesical therapy 57 aortic regurgitation 57 crossclamp 57 sirolimus eluting stents 57 coronary revascularization 57 graft dysfunction 57 p = NS 57 proximal femoral 57 hepatic veins 57 prespecified secondary 57 HbA 1c levels 57 graft occlusion 57 intracavitary 57 reinfarction 57 concurrent chemoradiation 57 mitral stenosis 57 femoral head 57 sigmoid colon 57 sonographically guided 57 #Gy 56 MACCE 56 histologic 56 systolic function 56 cTnI 56 prosthetic valve 56 resection 56 nephrectomies 56 noninferior 56 aortic crossclamp 56 pCR 56 endothelial keratoplasty 56 ipsilateral stroke 56 esophagectomy 56 dehiscence 56 nonoperative 56 postoperative radiographs 56 palliation 56 transcatheter closure 56 postop 56 tricuspid 56 intraoperatively 56 Kaplan Meier curves 56 LVEF 56 myocardial necrosis 56 tenecteplase 56 fibrinolysis 56 SUVmax 56 epicardial 56 intra operatively 56 infrapopliteal 56 cytoreductive surgery 56 pathologic diagnosis 56 intracoronary 56 atrioventricular valve 56 radical cystectomy 56 pulmonary resection 56 functional mitral regurgitation 56 lung resection 56 coronary artery occlusion 56 postprocedure 56 node dissection 56 neointimal hyperplasia 56 periprosthetic fracture 56 proximal DVT 56 FDG uptake 56 DES implantation 56 transfemoral 56 nodal metastases 56 stent stenosis 56 ischemic cardiomyopathy 56 fraction LVEF 56 artery stenosis 56 reintubation 56 adenoma recurrence 56 ischemia driven 56 trabeculectomy 56 debulking surgery 55 SVR# 55 colectomy 55 postintervention 55 MitraClip device 55 STARFlex ® 55 stenoses 55 postoperative morbidity 55 p = #.# [003] 55 angiographic follow 55 atrial pacing 55 Carotid artery 55 transesophageal echocardiography 55 joint contracture 55 radical nephrectomy 55 stent restenosis 55 systolic dysfunction 55 penetrating keratoplasty 55 suprapubic 55 superficial femoral 55 cytoreduction 55 paroxysmal AF 55 retropubic 55 Preoperatively 55 posttransplant 55 Patency 55 tibial tubercle 55 intimal 55 arterial occlusion 55 renal pelvis 55 QRS interval 55 ischemic lesions 55 restenotic lesions 55 XIENCE V PROMUS Stent 55 TAXUS Liberté stent 55 retransplantation 55 Fontan procedure 55 everolimus eluting stents 55 ureteric 55 varices 55 paracentesis 55 revascularizations 55 atrioventricular block 55 p ≤ 55 meniscectomy 55 urothelial 55 symptomatic VTE 55 reoperations 55 T1a 55 intraoperative 55 parathyroidectomy 55 echogenicity 55 R0 resection 55 CRp 55 revascularization procedures 55 target lesion revascularizations 55 TAVR 55 oncological outcomes 55 variceal 55 pelvic lymphadenectomy 55 LV dysfunction 55 recurrent ischemia 55 liver metastasis 55 tirofiban 55 myocardial reperfusion 55 Figure 1A 55 interobserver agreement 54 Ishak fibrosis score 54 mediastinitis 54 detectable HCV RNA 54 pacemaker implantation 54 cerebral vasospasm 54 thickness IMT 54 nondiabetic patients 54 valve implantation 54 anterior lumbar interbody fusion 54 urothelial carcinoma 54 occluded catheters 54 ostial 54 pulmonary dysfunction 54 pulmonary artery banding 54 epididymal 54 CCyR 54 preoperative PSA 54 sirolimus eluting 54 vasospasm 54 Taxus Stent 54 Secondary endpoints included 54 preoperatively 54 adrenalectomy 54 neurologic deficits 54 HSCT 54 chondral 54 ejection fraction EF 54 occlusive disease 54 coronary sinus 54 aortic coarctation 54 Intraoperative 54 bypass grafts 54 CDAI score 54 resections 54 PaO 2 54 mitral valve regurgitation 54 mL/min/#.# m 2 54 QTcF 54 median sternotomy 54 postoperative hemorrhage 54 laparotomy 54 echocardiographic 54 remission CR 54 venography 54 duodenal 54 arthrography 54 descending aorta 54 HeartMate XVE 54 biliary drainage 54 revascularization procedure 54 saphenous vein grafts 54 radiographically 54 hemiarthroplasty 54 wound dehiscence 54 Histologic 54 bi ventricular pacing 54 NIHSS score 54 HBeAg seroconversion 54 postoperatively 54 osteotomies 54 biventricular repair 54 ultrasonographic 54 prospectively defined 54 nephron sparing surgery 54 LVSD 54 nonfatal MI 54 transfemoral approach 54 Kaplan Meier analysis 54 hamartoma 54 diaphysis 54 esophageal carcinoma 54 transapical 54 peri procedural 54 Hgb 54 Duodenal 54 repeat revascularization 54 false lumen 53 scleral buckling 53 percutaneous transluminal coronary angioplasty 53 arteriography 53 intraocular pressure IOP 53 progression TTP 53 hydronephrosis 53 intratumoral 53 transabdominal 53 regurgitant 53 cholecystectomy 53 reimplantation 53 hepatic vein 53 efficacy endpoint 53 ventricular outflow tract 53 lung metastases 53 homograft 53 noncoronary 53 EBRT 53 Aortic valve 53 interobserver reliability 53 adnexal mass 53 resynchronization therapy 53 interquartile range IQR 53 malunion 53 jejunal 53 iliac crest 53 oral Hycamtin 53 hemoglobin A1c levels 53 Kaplan Meier 53 thromboembolic events 53 microsatellite instability 53 mesenteric 53 underwent radical cystectomy 53 perioperative complications 53 liver histology 53 percutaneous injection 53 Postoperative 53 arteriovenous fistula 53 % CI #.#-#.# [003] 53 mm Stent 53 thyroid carcinoma 53 composite endpoint 53 mitral regurgitation 53 XIENCE V demonstrated 53 renal artery stenting 53 aneurysm rupture 53 intracardiac 53 moderately emetogenic 53 tricuspid valves 53 intrathoracic 53 Ejection Fraction 53 ventricular remodeling 53 pathologic fracture 53 severe neutropenia 53 distal femur 53 postoperative chemotherapy 53 timepoint 53 histologic subtype 53 thyroglobulin 53 symptomatic intracranial hemorrhage 53 stented 53 aortic arch 53 glycated hemoglobin levels 53 rFVIIa 53 manometry 53 acetabular fractures 53 interquartile range 53 hypoperfusion 53 zotarolimus 53 -#.# ± [002] 53 chemoradiation therapy 53 prior relapsers 53 intraclass correlation coefficient 53 ‰ ¥ 53 artery occlusion 53 aortic insufficiency 53 TURBT 53 corneal curvature 53 biventricular 53 GORE TAG Device 53 ORIF 53 pulmonary regurgitation 53 NYHA class 53 anterograde 53 edifoligide 53 definite stent thrombosis 53 lavage 53 glycoprotein IIb IIIa inhibitors 53 pulsatile flow 53 unicompartmental knee arthroplasty 53 locoregional control 53 Key secondary endpoints 53 fibrinolytic therapy 53 pelvic lymph node dissection 53 percutaneous vertebroplasty 53 talar 53 lymphadenopathy 53 bivalirudin monotherapy 53 thoracic aortic aneurysms 53 mitral valve replacement 53 cellularity 53 intra aortic 53 fenestrated 53 distensibility 53 surgically resected 53 invasive angiography 53 hemorrhagic complications 53 carotid artery stenting CAS 53 reinterventions 53 noninferiority 53 SCr 53 p = .# [001] 53 esophagogastroduodenoscopy 53 reperfusion 53 postsurgical 53 cardiac perfusion 53 target lesion revascularization 53 Postoperatively 53 revascularisation procedures 53 pericardial 53 Y BOCS 53 IOP lowering 53 serum urate 53 endovascular aneurysm repair 53 pyloric 53 colorectal adenoma 53 luminal 53 #.#ng/ml 53 postoperative mortality 53 achieved statistical significance 53 evaluable subjects 53 stenosis 53 nodular partial response 53 hemoglobin Hb 53 malperfusion 52 intraoperative bleeding 52 radiotherapy RT 52 saphenous 52 thyroidectomy 52 peripheral vasculature 52 nadroparin 52 NMIBC 52 TAXUS Express Stent 52 nonfatal myocardial infarction 52 myocardial viability 52 posttreatment 52 thrombotic complications 52 Intracranial 52 LV ejection fraction 52 confirmed CCyR 52 intraperitoneal 52 Carotid endarterectomy 52 quantitative coronary angiography 52 valvular 52 FOLFOX4 52 subclavian 52 lymph node metastasis 52 ureteral stones 52 primary percutaneous coronary 52 perfusion defects 52 Cystectomy 52 response CCyR 52 carcinoids 52 mg kg dose 52 macular thickness 52 sirolimus stent 52 fatty infiltration 52 carotid stenosis 52 advanced adenoma 52 percutaneous nephrolithotomy 52 cardioplegic arrest 52 rt PA 52 GP IIb IIIa inhibitors 52 normothermic 52 dural 52 ventricular ejection fraction 52 contracture 52 hydroxyapatite coated 52 ALSFRS R 52 PSADT 52 revascularization 52 angulation 52 biliary obstruction 52 logMAR 52 MMSE score 52 haematologic 52 sternal closure 52 balloon occlusion 52 statistically significant p = 52 locoregional disease 52 AV fistula 52 CI -#.# 52 PASI scores 52 serum TSH 52 systemic hypotension 52 popliteal 52 events MACE 52 disease progression TTP 52 nodal metastasis 52 surgical revascularization 52 cerebral angiography 52 revision arthroplasty 52 hypoplasia 52 serum thyroglobulin 52 oncologic outcomes 52 contractile function 52 intact parathyroid hormone 52 total abdominal hysterectomy 52 pulmonary exacerbation 52 eptifibatide 52 TAXUS Express Atom Stent 52 CR CRu 52 sural nerve 52 elective PCI 52 uncoated stent 52 nonobstructive CAD 52 glomerular filtration 52 localized renal 52 angiographic outcomes 52 hemodynamically 52 hip resurfacing arthroplasty 52 incisional 52 sternal wound infections 52 ventricular dyssynchrony 52 carotid arterial 52 antral 52 endometrial thickness 52 thrombus formation 52 umbilical artery 52 physis 52 prognostic variables 52 pulmonary infiltrates 52 calcified plaques 52 Thrombolysis 52 paclitaxel eluting stents 52 arterial thromboembolic events 52 endophthalmitis 52 periprosthetic 52 subscore 52 cystic lesions 52 coronary stenoses 52 transvenous 52 locoregional 52 eluting stent 52 internal thoracic artery 52 intramedullary nailing 52 sigmoid 52 vasopressor 52 sirolimus eluting stent 52 thrombus aspiration 52 carotid artery blockage 52 thrombi 52 aortic root replacement 52 complete cytogenetic response 52 callus formation 52 virologic response 52 Coronary Artery Bypass Graft 52 CTEPH 52 Stent thrombosis 52 transapical approach 52 Myocardial Infarction TIMI 52 variceal hemorrhage 52 underwent surgical resection 52 descending thoracic aorta 52 hemodynamic variables 52 5-fluorouracil/leucovorin 52 endoleaks 52 refractory ischemia 52 Postoperative complications 52 venous reflux 52 ALND 52 bioprosthesis 52 NIHSS 52 lymphocytosis 52 tertile 52 troponin T 52 colorectal liver metastases 52 ximelagatran 52 hematuria 52 asystole 52 renal biopsy 52 extracapsular 52 mL kg 52 Annexin V 52 distant metastasis 52 selective cerebral perfusion 52 Circulating tumor cells 52 TAXUS Liberte Stent 52 coronary artery stenosis 52 Coronary artery bypass graft 52 bronchoalveolar lavage 51 lesional 51 multivessel disease 51 alteplase 51 transection 51 tissue oxygenation 51 achieving PASI 51 lamellar keratoplasty 51 myocardial fibrosis 51 Crohn Disease Activity 51 hepatic arterial 51 ileal 51 pain palliation 51 postoperative 51 lymph node involvement 51 pancreatic fistula 51 angioplasty stenting 51 left ventricular dysfunction 51 varus deformity 51 VT VF 51 ipsilateral 51 coronary artery bypass grafts 51 target vessel revascularization 51 #ng/ml 51 intraventricular 51 coronary intervention 51 sustained ventricular tachycardia 51 cm proximal 51 WOMAC scores 51 pulmonary capillary wedge 51 preoperative 51 hepatic insulin sensitivity 51 tracheal intubation 51 subclavian artery 51 CD# expression [002] 51 endovascular graft 51 hemodynamics 51 distant metastases 51 contralateral 51 IIIa inhibitor 51 coronary stenting 51 nonresponders 51 urinary N telopeptide 51 coronary bypass grafting 51 cardiovascular hospitalizations 51 extensor mechanism 51 interobserver 51 lumbar spinal fusion 51 mCi kg 51 cardiopulmonary bypass CPB 51 systemic embolism 51 cystoscopic 51 acute thrombosis 51 attain statistical significance 51 corneal astigmatism 51 intra abdominal 51 Major Adverse Cardiac 51 Hazard Ratio = 51 thromboembolism 51 Ebstein anomaly 51 ventricular dysfunction 51 guided percutaneous 51 ADAS cog 51 bioprosthetic 51 carotid intima media 51 TAXUS Liberte Long 51 unfractionated heparin UFH 51 Diastolic 51 rho = 51 RECIST Response Evaluation Criteria 51 cm H2O 51 perioperative morbidity 51 WallFlex Biliary RX 51 cavernous sinus 51 postdose 51 ischemic cerebrovascular 51 ventricular fibrillation VF 51 posttraumatic arthritis 51 oral anticoagulant therapy 51 vascular occlusion 51 seroma 51 intraobserver 51 balloon dilatation 51 arteriovenous 51 CK MB 51 TAXUS p value 51 thoracic aortic aneurysm 51 acute STEMI 51 liver metastases 51 cm2 51 infarct 51 postoperative radiotherapy 51 hemodynamic instability 51 serum aminotransferase levels 51 colon resection 51 percutaneous drainage 51 incomplete revascularization 51 spinal cord compression 51 leiomyoma 51 intima media thickness IMT 51 renal calculi 51 tracheobronchial 51 platelet inhibition 51 thromboses 51 curative resection 51 nonvascular 51 median PFS 51 acute aortic dissection 51 acute cholecystitis 51 FluCAM arm 51 calculi 51 intracerebral 51 pamidronate 51 antithrombotic therapy 51 endoprosthesis 51 tracheal stenosis 51 tumor progression TTP 51 coagulopathy 51 CABG coronary artery 51 Complication rates 51 axillary 51 preventing restenosis 51 chemoradiotherapy 51 detrusor 51 cerebral perfusion 51 RNFL thickness 51 appendiceal 51 multivariable analysis 51 paclitaxel eluting 51 metaplasia 51 pleural fluid 51 WOMAC pain 51 Intraocular pressure 51 villous atrophy 51 abdominal computed tomography 51 arthroplasties 51 diskectomy 51 hemoptysis 51 osseous 51 mCi 51 postinjury 51 mitral regurgitation MR 51 platelet reactivity 51 adnexal masses 51 Fig. 1D 51 bFGF 51 ventricular tachycardia VT 51 metastatic malignant 51 Free Survival PFS 51 secondary endpoint 51 urethral stricture 51 D dimer 51 HbA 1c 51 radical retropubic prostatectomy 51 bioprostheses 51 ≥ 50 paclitaxel eluting stent 50 lobar 50 Coronary artery bypass grafting 50 histological subtype 50 stent thromboses 50 postoperative infection 50 aplasia 50 prostate TURP 50 DAS# CRP 50 iliac crest bone 50 pmol 50 haematuria 50 tricuspid valve repair 50 % CI #.#-#.# [007] 50 severe mitral regurgitation 50 stent insertion 50 anagrelide 50 tuberosity 50 dalteparin 50 NYHA Class II 50 TAXUS Stent 50 cervical lymph nodes 50 nicardipine 50 androgen deprivation 50 periosteal 50 dimensional echocardiography 50 μg liter 50 hyperacute 50 clinicopathological features 50 mg/m2 dose 50 Bankart lesion 50 achieved PASI 50 SGRQ 50 leiomyomas 50 thromboembolic complications 50 subtrochanteric 50 Pegylated Liposomal Doxorubicin 50 hematologic toxicity 50 dural repair 50 p = #.# [002] 50 biliary tree 50 clodronate 50 ischaemia 50 ventricular myocardium 50 4mg/kg 50 thromboprophylaxis 50 osteolytic 50 eplerenone 50 kidney allograft 50 cerebrovascular events 50 euthyroid 50 postoperative bleeding 50 g cm 50 electrical cardioversion 50 ADCS CGIC 50 pseudophakic 50 arterial grafts 50 antibody titer 50 skeletal metastases 50 symptomatic intracranial 50 noncardiac 50 DHCA 50 ileus 50 hepatic resection 50 omental 50 receiving VICTRELIS 50 Radiographs 50 Flu Cy 50 platelet inhibitor 50 subtalar 50 autologous SCT 50 RBC transfusion 50 thoracotomy 50 tophi 50 thromboembolic 50 colorectal cancer liver metastases 50 autologous tissue 50 STRIDE PD 50 TIMI 50 cystoid macular edema 50 bioprosthetic valve 50 tumor recurrence 50 viable myocardium 50 lopinavir r arm 50 Visual Analogue Scale VAS 50 cardioverter defibrillator 50 BPH Symptom Score 50 carotid revascularization 50 anterior pelvic 50 stents BMS 50 BrachySil ™ 50 spontaneous circulation ROSC 50 arteriolar 50 NSTEMI 50 intervertebral 50 atorvastatin #mg 50 GP IIb IIIa inhibitor 50 sonographic findings 50 normothermia 50 thoracic aorta 50 underwent angiography 50 Endoprosthesis 50 β blockers 50 comparator arm 50 â ‰ ¥ 50 lactate dehydrogenase LDH 50 infarction 50 baroreflex 50 undergoing CABG 50 longus tendon 50 partial thromboplastin 50 symptomatic carotid stenosis 50 plasma uric acid 50 operable breast cancer 50 serum bilirubin 50 malignant neoplasm 50 aspartate aminotransferase 50 #mmHg [001] 50 recurrent GBM 50 carotid artery ICA 50 preterm neonates 50 Doppler sonography 50 spinal metastases 50 antireflux surgery 50 pleural effusion 50 joint arthroplasty 50 clinically meaningful improvement 50 mcg BID 50 capsular contracture 50 mitomycin 50 ertapenem 50 Index CDAI 50 advanced adenomas 50 XIENCE V stent 50 ulcer healing 50 IU ml 50 orchiectomy 50 Angiographic 50 serum magnesium 50 limb salvage 50 carcinoid tumor 50 pancreatectomy 50 myocardial infarction MI 50 bowel resection 50 HDRS 50 resected tumors 50 salivary flow 50 mcg mL 50 HOMA IR 50 pretransplant 50 OGTT 50 metastatic malignant melanoma 50 low dose Iluvien 50 dislodgement 50 labral 50 colonoscopic 50 knee arthroplasty 50 TAXUS stent 50 femoral fracture 50 Cypher Stent 50 cardiac dysfunction 50 plus dexamethasone 50 keratoplasty 50 Mitral valve 50 salmeterol fluticasone 50 vasculopathy 50 pancreatic duct 50 interrater reliability 50 pulmonary arterial 50 ROC curves 50 beta blocker therapy 50 hypothermic circulatory arrest 50 ICD implants 50 paresthesias 50 RYGB 50 mm Hg systolic 50 invasive aspergillosis 50 eosinophil count 50 imiquimod cream 50 sunitinib Sutent 50 χ 50 Doxil ® 50 HF hospitalization 50 histopathologic findings 50 ventricular septum 50 preoperative chemotherapy 50 mcg QD 50 bovine thrombin 50 mm3 50 cholecystitis 50 MBq 50 MIs 50 NNT = 50 septoplasty 50 resected pancreatic cancer 50 histological 50 donor nephrectomy 50 macular hole 50 neutrophil count 49 CryoValve SG 49 Index CDAI score 49 adenoidectomy 49 recurrent dislocation 49 UA NSTEMI 49 vertebrobasilar 49 repeat paracentesis 49 recurrent DVT 49 ischemia induced 49 #mg BID [001] 49 descending thoracic 49 lymphocyte count 49 surgically induced 49 stage IIIb IV 49 radiochemotherapy 49 non valvular atrial 49 peripheral artery 49 AST ALT 49 elbow arthroplasty 49 intimal hyperplasia